Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
CAPITAL-PRO
1 other identifier
interventional
400
1 country
1
Brief Summary
The objective of this study is to determine the rate of radial artery occlusion and vascular access site complications following transradial angiogram using a new Terumo (Tokyo, Japan) Glidesheath Slender, in comparison with the currently used 6 French (6 Fr.) radial sheath.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 8, 2014
CompletedFirst Posted
Study publicly available on registry
December 24, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 21, 2019
CompletedJanuary 28, 2022
January 1, 2022
4.2 years
December 8, 2014
January 27, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Radial artery occlusion
Evaluated clinically and by ultrasound
30 days
Secondary Outcomes (5)
Vascular access site complications
up to 30 days
Radial artery spasm
participants will be followed for the duration of hospital stay, an expected average of 1 day
Procedure success
participants will be followed for the duration of hospital stay, an expected average of 1 day
Sheath kinking
participants will be followed for the duration of hospital stay, an expected average of 1 day
Painful sheath removal
participants will be followed for the duration of hospital stay, an expected average of 1 day
Study Arms (2)
Glidesheath Slender
EXPERIMENTALThe transradial procedure will be performed using the glidesheath slender (studied sheath)
Standard sheath
ACTIVE COMPARATORThe transradial procedure will be performed using the standard 6- French radial sheath (comparator sheath)
Interventions
testing the efficacy and safety of the new transradial sheath in comparison to the standard 6 french sheath.
Eligibility Criteria
You may qualify if:
- Patients undergoing coronary angiography and/or PCI via transradial approach
- Informed consent
- Documented normal Allen's test
You may not qualify if:
- Patient who had a previous angiogram using the same radial artery
- Abnormal Allen's test
- Previous failed radial access.
- Known bleeding disorder or hypercoagulable condition
- Cardiogenic shock
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa Heart Institute
Ottawa, Ontario, K1Y 4W7, Canada
Related Publications (3)
Kotowycz MA, Johnston KW, Ivanov J, Asif N, Almoghairi AM, Choudhury A, Nagy CD, Sibbald M, Chan W, Seidelin PH, Barolet AW, Overgaard CB, Dzavik V. Predictors of radial artery size in patients undergoing cardiac catheterization: insights from the Good Radial Artery Size Prediction (GRASP) study. Can J Cardiol. 2014 Feb;30(2):211-6. doi: 10.1016/j.cjca.2013.11.021. Epub 2013 Nov 23.
PMID: 24461923BACKGROUNDAminian A, Dolatabadi D, Lefebvre P, Zimmerman R, Brunner P, Michalakis G, Lalmand J. Initial experience with the Glidesheath Slender for transradial coronary angiography and intervention: a feasibility study with prospective radial ultrasound follow-up. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):436-42. doi: 10.1002/ccd.25232. Epub 2013 Nov 6.
PMID: 24285594BACKGROUNDKotowycz MA, Dzavik V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012 Feb 1;5(1):127-33. doi: 10.1161/CIRCINTERVENTIONS.111.965871. No abstract available.
PMID: 22338002BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aun-Yeong Chong, MRCP, MD
University of Ottawa Heart Institute Research Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interventional Cardiologist
Study Record Dates
First Submitted
December 8, 2014
First Posted
December 24, 2014
Study Start
December 1, 2014
Primary Completion
March 1, 2019
Study Completion
March 21, 2019
Last Updated
January 28, 2022
Record last verified: 2022-01